PMV Pharmaceuticals
PMVP • NASDAQ
PMV Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David H. Mack, with a market cap of $69.9M.
CEODavid H. Mack
Next Earnings
Upcoming earnings announcement for PMV Pharmaceuticals
Date
Friday, May 8, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.39
Earnings History
Past 12 earnings reports for PMV Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 6, 2026 | Q4 2025 | -$0.34Est: -$0.40 | +15.0% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.40Est: -$0.40 | 0.0% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.41Est: -$0.39 | -5.1% | - | — | 10-Q |
| May 9, 2025 | Q1 2025 | -$0.34Est: -$0.38 | +10.5% | - | — | 10-Q |
| Mar 3, 2025 | Q4 2024 | -$0.45Est: -$0.38 | -18.4% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.37Est: -$0.35 | -5.7% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.02Est: -$0.33 | +93.9% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.30Est: -$0.37 | +18.9% | - | — | 10-Q |
| Feb 29, 2024 | Q4 2023 | -$0.31Est: -$0.39 | +20.5% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.34Est: -$0.45 | +24.4% | - | — | — |
| Aug 9, 2023 | Q2 2023 | -$0.38Est: -$0.47 | +19.1% | - | — | 10-Q |
| May 10, 2023 | Q1 2023 | -$0.42Est: -$0.46 | +8.7% | - | — | — |